Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis.
about
A comprehensive review of amyotrophic lateral sclerosisStem cell transplantation for motor neuron disease: current approaches and future perspectivesSpreading of pathology in neurodegenerative diseases: a focus on human studiesCalcium dysregulation links ALS defective proteins and motor neuron selective vulnerabilityThe complex molecular biology of amyotrophic lateral sclerosis (ALS)Mechanisms of neurodegeneration in amyotrophic lateral sclerosisCoculture of Primary Motor Neurons and Schwann Cells as a Model for In Vitro Myelination.Motor neurone disease.SOD1, an unexpected novel target for cancer therapySelective neuronal vulnerability to oxidative stress in the brain.Time Course Analysis of Gene Expression Patterns in Zebrafish Eye During Optic Nerve Regeneration.Inhibition of West Nile virus by calbindin-D28k.Cellular stress/the unfolded protein response: relevance to sleep and sleep disorders.Glial cell inclusions and the pathogenesis of neurodegenerative diseasesGlial proliferation and metabotropic glutamate receptor expression in amyotrophic lateral sclerosis.Mutant TDP-43 deregulates AMPK activation by PP2A in ALS models.Molecular and cellular pathways of neurodegeneration in motor neurone diseaseMotoneuron subtypes show specificity in glycine receptor channel abnormalities in a transgenic mouse model of amyotrophic lateral sclerosis.Alterations in G(1) to S phase cell-cycle regulators during amyotrophic lateral sclerosis.Vascular endothelial growth factor and the nervous system.Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo.Dysregulated expression of death, stress and mitochondrion related genes in the sciatic nerve of presymptomatic SOD1(G93A) mouse model of Amyotrophic Lateral Sclerosis.Implications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis.Intraperitoneally administered IgG from patients with amyotrophic lateral sclerosis or from an immune-mediated goat model increase the levels of TNF-α, IL-6, and IL-10 in the spinal cord and serum of mice.Nutrition and dietary supplements in motor neuron disease.Ionotropic glutamate receptors & CNS disorders.ALS and oxidative stress: the neurovascular scenarioChronic intermittent hypoxia affects endogenous serotonergic inputs and expression of synaptic proteins in rat hypoglossal nucleus.ALS Pathogenesis and Therapeutic Approaches: The Role of Mesenchymal Stem Cells and Extracellular VesiclesMetabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic TreatmentsVoltage-gated calcium channels are abnormal in cultured spinal motoneurons in the G93A-SOD1 transgenic mouse model of ALS.Calcium ions promote superoxide dismutase 1 (SOD1) aggregation into non-fibrillar amyloid: a link to toxic effects of calcium overload in amyotrophic lateral sclerosis (ALS)?Linking selective vulnerability to cell death mechanisms in Parkinson's disease.Protective activity of aromatic amines and imines against oxidative nerve cell death.Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats.Differential expression of voltage-activated calcium channels in III and XII motoneurones during development in the rat.Blocked gap junctional coupling increases glutamate-induced neurotoxicity in neuron-astrocyte co-cultures.Optimized methods for rapidly dissecting spinal cords and harvesting spinal motor neurons with high survival and purity from rats at different embryonic stages.Energy metabolism in ALS: an underappreciated opportunity?Real-time visualization of oxidative stress-mediated neurodegeneration of individual spinal motor neurons in vivo
P2860
Q26775401-83E30446-5566-44B8-8C84-C3CEAF9301C3Q26995278-8C4A62CB-A13A-4DFB-8F99-8B065303AF72Q28082279-173B6CA7-DD65-4F3E-B61C-151B2C398CA4Q28084373-F26CBC6B-BFE8-4FA0-848A-0499645A18DEQ28263899-B289C815-299C-4263-B361-09112B87D965Q28365454-31D8156B-429E-4616-8898-2F194DD713A1Q30667587-BCC83514-7E53-4404-8048-6F436C6F82A3Q33600152-434BE0D1-8188-410B-8C43-21BFD898BCE4Q33776847-6D30AD54-1C91-414A-A9DE-834463158AE2Q33868370-616C39B5-262C-49EB-894C-6111B71E6DDFQ34080374-8CE2D0DC-974D-4789-9D88-DA843DCD3DC8Q34122546-6150C8CD-D7E5-4528-8D2D-11E4D6565B7BQ34241641-8AE42CD7-1E8C-48C8-9EEA-2D2F7F6D6CC3Q34538330-6240A4CA-AC4D-49BA-B7CF-0C6E46DC1595Q34550482-2225214C-9167-4F46-9217-893F33CB162CQ35111080-9E255587-F205-4D8B-BF74-CE3845CCB0BEQ35489359-747D5B6A-ACC7-44CC-A735-A1D260555ECAQ35577690-22A3B5C9-BCB6-4D28-BFD6-FEC1F983CAD0Q35791339-452D93EA-FB29-4998-9796-A38DA346A947Q35919917-D64AA2EF-95C8-4F44-B9F3-03E194670258Q35933131-FE086B96-A56E-4801-83A1-1C9E198CF5BDQ36012034-67519D2F-23E3-4B91-B6A4-4B8EE03073F1Q36565671-FB7D60C9-FCF2-4C13-BF0D-80AC1321FBCEQ36934383-346CF603-5C85-4E4F-A27A-C26F32FB9765Q37073851-80797106-63DB-42E0-8381-F671BE2962A7Q37143580-A1CA3208-140D-482D-BBAE-F531B59832FCQ37400451-29249226-DD60-4E27-A47A-7E503544EEBCQ37685252-86F0A99C-B15E-4F3D-8978-39FA34B1C4A2Q37712624-884408C6-C5C6-4E0D-AF0F-D2FFCF00349FQ39101800-4F43F3C8-1929-4E51-BEF9-A07BF2D5CA78Q41842390-9D679680-4E57-4AF2-8A1A-3740778E7768Q41955617-1E7D23FF-74FC-4F25-AC02-897C058BB0CBQ42121950-ED2B10DD-31A6-4591-BC2F-728E5340B42CQ43840174-9A9A57A1-C018-4775-92C5-E03C7E64D647Q44658133-530968B8-B37D-4472-A7E5-5D568E441196Q45014653-2B936EB9-DCFA-4B9A-9B49-2E008635573BQ45713210-CC5D890D-5963-40F9-ABFC-DC109D2F666CQ50436779-D95600E5-47C4-4365-84DA-9C751A906CF7Q52651163-5F5C6200-4455-41E7-97D1-0365B88183FFQ58711477-FE5EF512-1FEC-45AD-8527-BCB206E6293D
P2860
Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Molecular factors underlying s ...... amyotrophic lateral sclerosis.
@ast
Molecular factors underlying s ...... amyotrophic lateral sclerosis.
@en
type
label
Molecular factors underlying s ...... amyotrophic lateral sclerosis.
@ast
Molecular factors underlying s ...... amyotrophic lateral sclerosis.
@en
prefLabel
Molecular factors underlying s ...... amyotrophic lateral sclerosis.
@ast
Molecular factors underlying s ...... amyotrophic lateral sclerosis.
@en
P356
P1433
P1476
Molecular factors underlying s ...... amyotrophic lateral sclerosis.
@en
P2093
P304
P356
10.1007/S004150050553
P478
247 Suppl 1
P577
2000-03-01T00:00:00Z